Pharmaceuticals – CoolPal

Novo Nordisk Slashes Ozempic Price by Half in US Market

2025-08-19 CoolPal

Novo Nordisk Slashes Ozempic Price by Half in US Market Novo Nordisk has announced a significant reduction in the US price of its popular diabetes and weight-loss drug, Ozempic, effectively halving its cost for consumers. This move by the Danish pharmaceutical giant is expected to have a substantial impact on healthcare accessibility and affordability in the United States, particularly for the millions of Americans managing Type 2 diabetes and obesity. The decision comes amidst ongoing public and political pressure on…

Pfizer Boosts 2025 Profit Forecast on Strong Quarterly Performance, Cost Efficiencies

2025-08-05 CoolPal

Pfizer Boosts 2025 Profit Forecast on Strong Quarterly Performance, Cost Efficiencies Pharmaceutical giant Pfizer has significantly raised its profit outlook for 2025, citing robust quarterly results and successful cost-cutting measures. The updated forecast reflects the company’s strong financial performance and its strategic initiatives to enhance profitability. This positive revision comes as Pfizer continues to navigate the evolving healthcare landscape, with its recent earnings indicating a solid operational performance and effective expense management. The announcement is expected to be a key…

Trump Declares Major Tariffs on Copper and Pharmaceuticals, Sending Markets Reeling

2025-07-09 CoolPal

Trump Declares Major Tariffs on Copper and Pharmaceuticals, Sending Markets Reeling President Donald Trump has announced a sweeping new 50% tariff on all copper imported into the United States, a move that immediately sent copper prices surging to all-time highs. Speaking at a Cabinet meeting on Tuesday, President Trump confirmed the significant levy, though the exact implementation timeline remains unclear. This marks the fourth broad tariff imposed by the Trump administration during its second term, following existing duties on imported…

CoolPal

Embracing tech together, continuous learning, mutual growth.

Browsed by
Tag: Pharmaceuticals